Serum thymidine kinase and soluble interleukin-2 receptor predict recurrence of malignant lymphoma.
Wakao D, Murohashi I, Tominaga K, Yoshida K, Kishimoto K, Yagasaki F, Itoh Y, Itoh K, Sakata T, Kawai N, Kayano H, Suzuki T, Matsuda A, Hirashima K, Bessho M.
Wakao D, et al. Among authors: kayano h.
Ann Hematol. 2002 Mar;81(3):140-6. doi: 10.1007/s00277-001-0421-8. Epub 2002 Feb 9.
Ann Hematol. 2002.
PMID: 11904739